Comparative effectiveness of hypoxia-inducible factor prolyl hydroxylase inhibitors versus erythropoiesis-stimulating agents on prognosis in non-dialysis chronic kidney disease: a propensity-matched cohort study.

Mortality analysis ( Figure 2 ) Kaplan-Meier analysis showed a significantly lower all-cause mortality in the HIF group compared to the ESA group, with a highly significant log-rank test ( p < 0.0001), indicating improved survival among HIF users.

also in 132,142 other papers

LDL cholesterol, glucose, and GFR values also favored the ESA group, though some differences did not reach statistical significance.

also in 111,027 other papers